AML MRD Flow Panel

Submitted by Anonymous (not verified) on
Code
FLG-AMLX-03BX
Panel
Active-Compendium
88184x1, 88185x19. Add 88189x1 for Global
Clinical
Oncology,Pathology
Bone marrow aspirate: 2-3 mL, first pull.  EDTA preferred. Sodium heparin tube acceptable. Lithium heparin or ACD (pale yellow/no gel separator) not acceptable. Please provide recent CBC report.
Hematologic Diseases
Acute myeloid leukemia (AML)
Flow Cytometry
Global
Flag Active
True
Orderable Test Description
<p>Available as Global test only. Markers are CD7, CD11b, CD13, CD14, CD15, CD16, CD19, CD2, CD33, CD34, CD38, CD4, CD45, CD56, CD64, CD65, CD87, CD117, CD371, HLA-DR (20 markers). This panel can detect MRD at the 0.01% level.</p>
Orderable Turn Around Time
1 Day
Keywords
acute myeloid leukemia flow
AML MRD
aml minimal residual disease
AML flow
AML
Meta Description
<p>MRD assessment has the potential to improve outcomes for patients with acute myeloid leukemia (AML).</p>
Extra Note

Lithium heparin or ACD (pale yellow/no gel separator) is not acceptable. Please provide recent CBC report. Use cold pack for transport, making sure cold pack is not in direct contact with specimen.

Orderable Biomarkers
CD4
CD87
CD371
CD117
CD19
CD11b
CD34
CD13
CD14
CD16
CD33
CD64
HLA-DR
CD38
CD2
CD56
CD7
CD15
CD65
CD45
NY Approved
True
Orderable Biomarkers JSON
{"Flow Cytometry": {"Markers": ["CD4", "CD87", "CD371", "CD117", "CD19", "CD11b", "CD34", "CD13", "CD14", "CD16", "CD33", "CD64", "HLA-DR", "CD38", "CD2", "CD56", "CD7", "CD15", "CD65", "CD45"]}}
Keywords string
acute myeloid leukemia flow, AML MRD, aml minimal residual disease, AML flow, AML AML MRD Flow Panel
Title URL
aml-mrd-flow-panel